Pacific BioLabs Acquires Bay Bioanalytical Laboratory

Analytical Chemistry and Bioanalytical Added to PBL’s Service Offerings

HERCULES, CA – November 1, 2012

Pacific BioLabs (PBL), "The Service Leader in Bioscience Testing", has acquired Bay Bioanalytical Laboratory (BBL), adding analytical and bioanalytical chemistry to PBL’s existing in vivo preclinical and microbiological testing services.

Calls for action on unlicensed medicines

Four European patient groups have called for more and improved measures against the use of unlicensed and off-label medicines.

The European Alliance for Access to Safe Medicines (EAASM), the European Federation of Neurological Associations, the European Men's Health Forum and the European Depression Association all signed a statement demanding mandatory reporting by healthcare professionals of adverse events involving unlicensed and off-label use of medicines.

Industry pledges action on global NCD rise

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has said the industry plans to address the rise of non-communicable disease (NCDs), such as diabetes and cancer, in developing nations.